244 related articles for article (PubMed ID: 19894009)
1. Botulinum toxin type A in the healing of a chronic buttock ulcer in a patient with spastic paraplegia after spinal cord injury.
Intiso D; Basciani M
J Rehabil Med; 2009 Nov; 41(13):1100-2. PubMed ID: 19894009
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type A in the healing of chronic lesion following bilateral spasticity of gluteus muscle.
Cigna E; Maruccia M; Fanelli B; Scuderi N
Int Wound J; 2014 Aug; 11(4):412-5. PubMed ID: 23078619
[TBL] [Abstract][Full Text] [Related]
3. Effect of intrathecal baclofen, botulinum toxin type A and a rehabilitation programme on locomotor function after spinal cord injury: a case report.
Santamato A; Panza F; Ranieri M; Amoruso MT; Amoruso L; Frisardi V; Solfrizzi V; Fiore P
J Rehabil Med; 2010 Oct; 42(9):891-4. PubMed ID: 20878052
[TBL] [Abstract][Full Text] [Related]
4. Has botulinum toxin type A a place in the treatment of spasticity in spinal cord injury patients?
Al-Khodairy AT; Gobelet C; Rossier AB
Spinal Cord; 1998 Dec; 36(12):854-8. PubMed ID: 9881735
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin type A in the healing of ulcer following oro-mandibular dyskinesia in a patient in a vegetative state.
Intiso D; Basciani M; Di Rienzo F; Tolfa M; Grimaldi G; Fiore P
J Rehabil Med; 2008 Apr; 40(4):315-6. PubMed ID: 18382829
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
Opara J; Hordyńska E; Swoboda A
Ortop Traumatol Rehabil; 2007; 9(3):277-85. PubMed ID: 17721426
[TBL] [Abstract][Full Text] [Related]
7. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial.
Marco E; Duarte E; Vila J; Tejero M; Guillen A; Boza R; Escalada F; Espadaler JM
J Rehabil Med; 2007 Jul; 39(6):440-7. PubMed ID: 17624477
[TBL] [Abstract][Full Text] [Related]
8. Treatment of spasticity in spinal cord injury with botulinum toxin.
Palazón-García R; Alcobendas-Maestro M; Esclarin-de Ruz A; Benavente-Valdepeñas AM
J Spinal Cord Med; 2019 May; 42(3):281-287. PubMed ID: 29869974
[TBL] [Abstract][Full Text] [Related]
9. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
10. [Botulinum toxin in spasticity treatment].
Sławek J
Neurol Neurochir Pol; 1998; 32 Suppl 1():71-84. PubMed ID: 9608556
[TBL] [Abstract][Full Text] [Related]
11. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients.
Carda S; Invernizzi M; Baricich A; Cisari C
Clin Rehabil; 2011 Dec; 25(12):1119-27. PubMed ID: 21729974
[TBL] [Abstract][Full Text] [Related]
12. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury].
Xing ST; Wang D; Wen XH; Wu ZQ; Sun Q; Zhang DW; Cheng Y; Yan D; Yu F
Zhongguo Gu Shang; 2010 May; 23(5):350-3. PubMed ID: 20575288
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report.
Santamato A; Ranieri M; Panza F; Frisardi V; Micello MF; Filoni S; Fiore P
J Rehabil Med; 2012 Sep; 44(9):795-7. PubMed ID: 22915045
[TBL] [Abstract][Full Text] [Related]
14. Effect of single botulinum toxin A injection to the external urethral sphincter for treating detrusor external sphincter dyssynergia in spinal cord injury.
Chen SL; Bih LI; Huang YH; Tsai SJ; Lin TB; Kao YL
J Rehabil Med; 2008 Oct; 40(9):744-8. PubMed ID: 18843427
[TBL] [Abstract][Full Text] [Related]
15. Walking assessment with instrumented insoles in patients with lower limb spasticity after botulinum toxin infiltration.
Béseler MR; Grao CM; Gil A; Martínez Lozano MD
Neurologia; 2012; 27(9):519-30. PubMed ID: 22088852
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A for rehabilitation after a spinal cord injury: a case report.
Naicker AS; Roohi SA; Chan JL
J Orthop Surg (Hong Kong); 2009 Apr; 17(1):96-9. PubMed ID: 19398803
[TBL] [Abstract][Full Text] [Related]
17. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
Barrett RS
Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
[No Abstract] [Full Text] [Related]
18. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
19. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain.
Han ZA; Song DH; Chung ME
Spinal Cord; 2014 Jun; 52 Suppl 1():S5-6. PubMed ID: 24902645
[TBL] [Abstract][Full Text] [Related]
20. Healing hand ulcers caused by focal spasticity.
Gupta AD; Addison S
Int Wound J; 2020 Jun; 17(3):774-780. PubMed ID: 32135027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
